Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER2 amplification in gastric cancer is a rare event restricted to the intestinal phenotype.

International journal of surgical pathology - 1 Jun 2013

Cruz-Reyes Carolina, Gamboa-Dominguez Armando

Abstract excerpt

The objectives of this study were to identify HER2 prevalence in gastric cancer and correlate it with location, phenotype, and follow-up. Consecutive gastric cancer patients with tissue blocks, gross data, and follow-up data, were submitted to immunohistochemistry (IHC) with HercepTest. Chromogenic and fluorescence in situ hybridization was performed in IHC-positive tumors. A total of 269 patients were included...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biopsy
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrectomy

Share to Gene Amplification

Share to In Situ Hybridization, Fluorescence

Share to Receptor, ErbB-2

Share to Stomach Neoplasms

Source

Identifiers

PMID: 23564704
DOI: 10.1177/1066896913481055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER2 amplification in gastric cancer is a rare event restricted to the intestinal phenotype.PMID 23564704Read ↗

HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists.Semantic proximity Read ↗

Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristicsSemantic proximity Read ↗

EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagusSemantic proximity Read ↗

A study of HER2 gene amplification and protein expression in gastric cancerSemantic proximity Read ↗

FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohortSemantic proximity Read ↗

[Molecular Subtypes of Gastric Cancer].Semantic proximity Read ↗

Pathologic and phenotypic features of gastric cancer.Semantic proximity Read ↗

A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer.Semantic proximity Read ↗

HER2 Amplification and PD-L1 Expression in Advanced Gastric Cancer: Correlations, Clinical Implications, and Molecular CharacteristicsSemantic proximity Read ↗

Current and future therapies for targeting HER2 mutations in gastrointestinal cancer.Semantic proximity Read ↗

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesisSemantic proximity Read ↗

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.